What is Acrivon Therapeutics, Inc. Common Stock's Market Cap?

Acrivon Therapeutics, Inc. Common Stock's Market Cap is $88.5M, based on as-reported figures from SEC (XBRL) filings.

What is Acrivon Therapeutics, Inc. Common Stock's Enterprise Value?

Acrivon Therapeutics, Inc. Common Stock's Enterprise Value is -$1.5M, based on as-reported figures from SEC (XBRL) filings.

What is Acrivon Therapeutics, Inc. Common Stock's EV / EBITDA?

Acrivon Therapeutics, Inc. Common Stock's EV / EBITDA is 0.0×, based on as-reported figures from SEC (XBRL) filings.

What is Acrivon Therapeutics, Inc. Common Stock's Net Income (TTM)?

Acrivon Therapeutics, Inc. Common Stock's Net Income (TTM) is -$74.2M, based on as-reported figures from SEC (XBRL) filings.

What is Acrivon Therapeutics, Inc. Common Stock's EBITDA?

Acrivon Therapeutics, Inc. Common Stock's EBITDA is -$76.9M, based on as-reported figures from SEC (XBRL) filings.

What is Acrivon Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Acrivon Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.73, based on as-reported figures from SEC (XBRL) filings.

What is Acrivon Therapeutics, Inc. Common Stock's Net Debt?

Acrivon Therapeutics, Inc. Common Stock's Net Debt is -$90.0M, based on as-reported figures from SEC (XBRL) filings.

Acrivon Therapeutics, Inc. Common Stock (ACRV) Financial Statements

Acrivon Therapeutics, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG011RWR2R3

XNAS · usd

2.07▼ 0.04 (-1.67%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close2.10

Day's Range2.07 – 2.18

52-Week Range1.27 – 3.56

Volume126.4K

Avg Volume347.0K

Share Statistics

Shares Outstanding

Employees76

ExchangeXNAS

Listed2022-11-15

Share count as of August 7, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Acrivon Therapeutics, Inc. Common Stock (ACRV)

What is Acrivon Therapeutics, Inc. Common Stock's Market Cap?: Acrivon Therapeutics, Inc. Common Stock's Market Cap is $88.5M, based on as-reported figures from SEC (XBRL) filings.
What is Acrivon Therapeutics, Inc. Common Stock's Enterprise Value?: Acrivon Therapeutics, Inc. Common Stock's Enterprise Value is -$1.5M, based on as-reported figures from SEC (XBRL) filings.
What is Acrivon Therapeutics, Inc. Common Stock's EV / EBITDA?: Acrivon Therapeutics, Inc. Common Stock's EV / EBITDA is 0.0×, based on as-reported figures from SEC (XBRL) filings.
What is Acrivon Therapeutics, Inc. Common Stock's Net Income (TTM)?: Acrivon Therapeutics, Inc. Common Stock's Net Income (TTM) is -$74.2M, based on as-reported figures from SEC (XBRL) filings.
What is Acrivon Therapeutics, Inc. Common Stock's EBITDA?: Acrivon Therapeutics, Inc. Common Stock's EBITDA is -$76.9M, based on as-reported figures from SEC (XBRL) filings.
What is Acrivon Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Acrivon Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.73, based on as-reported figures from SEC (XBRL) filings.
What is Acrivon Therapeutics, Inc. Common Stock's Net Debt?: Acrivon Therapeutics, Inc. Common Stock's Net Debt is -$90.0M, based on as-reported figures from SEC (XBRL) filings.